A 65-year-old male patient with a past medical history of prostate adenocarcinoma presented with biochemical recurrence (prostate-specific antigen level of 5.91 mg/L). F-FACBC PET/CT was acquired to evaluate the disease recurrence and metastasis. Multifocal areas of tracer uptake localized to the dural surface of frontal convexities and cavernous sinuses were seen. Subsequent MRI confirmed lesions to be consistent with multifocal meningiomas. Focal intracranial 18F-fluciclovine radiotracer uptake especially at the skull base may present with a diagnostic challenge, and it may be difficult to differentiate between bone metastasis and meningiomas.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517046 | PMC |
| http://dx.doi.org/10.1007/s13139-021-00715-5 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Advances in diffuse glioma assessment: preoperative and postoperative applications of chemical exchange saturation transfer.
Front Neurosci
July 2024
Department of Radiology, The First Affiliated Hospital of Shenzhen University, Health Science Center, Shenzhen Second People's Hospital, Shenzhen, China.
Chemical Exchange Saturation Transfer (CEST) is a technique that uses specific off-resonance saturation pulses to pre-saturate targeted substances. This process influences the signal intensity of free water, thereby indirectly providing information about the pre-saturated substance. Among the clinical applications of CEST, Amide Proton Transfer (APT) is currently the most well-established.
View Article and Find Full Text PDFRegression of all untreated lesions in multifocal low-grade meningioma following fractionated stereotactic radiotherapy-abscopal effect or spontaneous regression? : Case report and review of the literature.
Strahlenther Onkol
June 2024
Department of Neurosurgery/Stereotactic Radiotherapy, Wege Klinik, Villenstr. 8, 53129, Bonn, Germany.
Purpose: Abscopal effects have been reported predominantly in metastatic cancers, indicating a radiographic response in a lesion that has not been included in the radiotherapy target volume. The response is interpreted as a humoral immune response to radiotherapy-generated tumour-specific antigens. In this case study, we present the first histologically confirmed multifocal low-grade meningioma with spontaneous regression of all other lesions after conventionally fractionated stereotactic radiotherapy (RT).
View Article and Find Full Text PDFParasagittal meningeal hemangiopericytoma/solitary fibrous tumor: Two case reports and a literature review.
Surg Neurol Int
April 2024
Department of Neurosurgery, Acibadem City Clinic University Hospital Tokuda, Sofia, Bulgaria.
Background: Solitary fibrous tumor/meningeal hemangiopericytoma (SFT/M-HPC) is a rare neoplasm which accounts for around 1% of the intracranial masses. This pathology has a high risk for recurrence and metastasis to distant locations such as the liver, lungs, and bones. Precise diagnosis necessitates detailed histopathological examination.
View Article and Find Full Text PDFGrowth dynamics of untreated meningiomas.
Neurooncol Adv
December 2023
Department of Neurosurgery, St. Olavs University Hospital, Trondheim, Norway.
Background: Knowledge about meningioma growth characteristics is needed for developing biologically rational follow-up routines. In this study of untreated meningiomas followed with repeated magnetic resonance imaging (MRI) scans, we studied growth dynamics and explored potential factors associated with tumor growth.
Methods: In a single-center cohort study, we included 235 adult patients with radiologically suspected intracranial meningioma and at least 3 MRI scans during follow-up.
A Prospective Registry Study of Ga-DOTATATE PET/CT Incorporation Into Treatment Planning of Intracranial Meningiomas.
Int J Radiat Oncol Biol Phys
March 2024
Department of Radiation Oncology, Ohio State University Wexner Medical Center, Columbus, Ohio. Electronic address:
Purpose: The current standard for meningioma treatment planning involves magnetic resonance imaging-based guidance. Somatostatin receptor ligands such as Ga-DOTATATE are being explored for meningioma treatment planning due to near-universal expression of somatostatin receptors 1 and 2 in meningioma tissue. We hypothesized that Ga-DOTATATE positron emission tomography (PET)-guided treatment management for patients with meningiomas is safe and effective and can identify which patients benefit most from adjuvant radiation therapy.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!